Distribution of pharmaceutical products through a local partner in the GCC
Type
E-journal
Date
4 Oct 2016
Jurisdiction
Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
Taxonomy
Pharmacy, Drugs & Medicinal Products, General Commercial Law
Copyright
LexisNexis
Relevant company
Clyde & Co
Analysis
The pharmaceutical and healthcare sector in the GCC region has over the past few years enjoyed one of the most robust growth rates in the world with an average annual growth considerably larger than that of other regions.
This growth has been driven by the expanding middle class (which has more income to spend on non-prescription healthcare products) and the continued importance placed by local governments on well-funded healthcare programs. This growth is also partly driven by the use of the GCC region as a base for expansion into nearby developing markets such as Africa and this is particularly true of manufacturers of generic drugs.